SAFIA Technologies
PrivateLast Round
Grant
Jul 11, 2024
Total Funding Raised
$12,855
Momentum Score
25 /100
Company Overview
SAFIA Technologies is a biotechnology company that develops and markets antibody-based analysis kits (immunoassays) for the detection of mycotoxins in food and animal feed.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Environmental Monitoring, Quality Management
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SAFIA Technologies Comps
Public and private peers based on sector, stage, and business model.
SAFIA Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 11, 2024 | ||||
| Grant | Sep 7, 2023 |
SAFIA Technologies Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 21, 2026
Grew 83% QoQ, from 6 to 11 employees.
- Jul 11, 2024
$11K grant round completed.
SAFIA Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SAFIA Technologies's valuation, stock price, and market status.
